Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.
Fluorescence imaging has the potential to significantly improve neurosurgical resection of oncologic lesions through improved differentiation between normal and cancerous tissue at the tumor margins. In order to successfully mark glioma tissue a fluorescent tracer must have the ability to penetrate...
Main Authors: | Kristian Sexton, Kenneth Tichauer, Kimberley S Samkoe, Jason Gunn, P Jack Hoopes, Brian W Pogue |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3625207?pdf=render |
Similar Items
-
Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens
by: Yao Chen, et al.
Published: (2023-02-01) -
Affibody-Binding Ligands
by: Annalisa Barozzi, et al.
Published: (2020-05-01) -
Affibody Molecules as Targeting Vectors for PET Imaging
by: Vladimir Tolmachev, et al.
Published: (2020-03-01) -
Electrophilic affibodies forming covalent bonds to protein targets.
by: Holm, L, et al.
Published: (2009) -
Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy
by: Federica Gabriele, et al.
Published: (2023-05-01)